Upgrade to SI Premium - Free Trial

Arcturus Therapeutics to present Phase 2 OTC deficiency data

September 18, 2026 9:00 AM
Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) announced it will host a virtual presentation on September 23, 2026, at 4:30 p.m ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA